Palo Alto Investors »

First Tracks Biotherapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 604k 20.12

More positions owned by Palo Alto Investors

Ptc Therapeutics I (PTCT)
ACADIA Pharmaceuticals (ACAD)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Anaptysbio Inc Common (ANAB)
BioMarin Pharmaceutical (BMRN)
Dyne Therapeutics (DYN)
United Therapeutics Corporation (UTHR)
Disc Medicine (IRON)
Biogen Idec (BIIB)
Iovance Biotherapeutics (IOVA)
Ultragenyx Pharmaceutical (RARE)
Novocure Ord Shs (NVCR)
Syndax Pharmaceuticals (SNDX)
Annexon (ANNX)

View all positions for Palo Alto Investors

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management
Bank of America Corporation
Palo Alto Investors

View all funds holding First Tracks Biotherapeutics